The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas
Abstract
Phaeochromocytomas arising in adrenal or extra-adrenal sites and paragangliomas of the head and neck, in particular of the carotid bodies, occur sporadically and also in a familial setting. In addition to mutations in RET and VHL in familial disease, germline mutations in SDHD and SDHB genes that encode subunits of mitochondrial complex II have also been associated with the development of familial phaeochromocytomas. To further investigate the role of SDHD and SDHB in the development of these tumours we determined the occurrence of germline SDHD and SDHB mutations in four patients with a family history of phaeochromocytoma with associated head and neck paraganglioma, one patient with a family history of phaeochromocytoma only and two patients with apparently sporadic extra-adrenal phaeochromocytoma, one of whom had early onset disease. Secondly, we investigated whether somatic SDHB mutations correlated with loss of heterozygosity at 1p36 in a subgroup of 11 sporadic and three MEN 2-associated RET-mutation-positive phaeochromocytomas. Novel SDHB mutations were identified in the probands from four families and two apparently sporadic cases (six of seven probands studied), including two missense mutations, a single nonsense and frameshift mutation, as well as two splice site mutations, one of which was shown to have partial penetrance resulting in 'leaky' splicing. Further, five intronic polymorphisms in SDHB were found. No SDHD mutations were identified. In addition, no somatic SDHB mutations were found in the remaining allele of the 11 sporadic adrenal phaeochromocytomas with allelic loss at 1p36 or the three MEN 2-associated RET-mutation-positive phaeochromocytomas. Therefore, we conclude that SDHB has a major role in the pathogenesis of familial phaeochromocytomas, but the possible role of SDHB in sporadic tumours showing allelic loss at 1p36 has yet to be ascertained.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite ubiquitous expression of the metabolic enzyme succinate dehydrogenase (SDH), germline mutations in subunits of this complex cause cancer only in a few sites, including neuroendocrine tissues (paraganglioma), the adrenal gland (pheochromocytoma), and the stomach and small intestine (gastrointestinal stromal tumors) (8–10).”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [9]
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638
Germ-Line Mutations in Nonsyndromic Pheochromocytoma
Neumann, H. P. H., Bausch, B., McWhinney, S. R., Bender, B., Gimm, O., Franke, G., Schipper, J., Klisch, J., Altehoefer, C., Zerres, K., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020152 · Cited by 1,350
Astuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087
Mutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Histological Typing of Endocrine Tumours
Solcia, E., Klöppel, G., & Sobin, L. H. (2000) · Springer eBooks · doi:10.1007/978-3-642-59655-1 · Cited by 747
Baysal, B. E., Willett-Brozick, J. E., Lawrence, E. C., Drovdlic, C. M., Savul, S. A., McLeod, D. R., Yee, H. A., Brackmann, D. E., Slattery, W. H., Myers, E. N., et al. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.3.178 · Cited by 336
Germline SDHD mutation in familial phaeochromocytoma
Astuti, D., Douglas, F., Lennard, T. W., Aligianis, I. A., Woodward, E. R., Evans, D. G. R., Eng, C., Latif, F., & Maher, E. R. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04378-6 · Cited by 246
Functional Consequences of a SDHB Gene Mutation in an Apparently Sporadic Pheochromocytoma
Gimenez-Roqueplo, A.-P., Favier, J., Rustin, P., Rieubland, C., Kerlan, V., Plouin, P.-F., Rötig, A., & Jeunemaitre, X. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020525 · Cited by 209
Eng, C., Crossey, P. A., Mulligan, L. M., Healey, C. S., Houghton, C. A., Prowse, A. H., Chew, S. L., Dahia, P. L. M., O'Riordan, J. L. H., & Toledo, S. P. A. (1995) · Journal of Medical Genetics · doi:10.1136/jmg.32.12.934 · Cited by 167
Taschner, P. E. M., Jansen, J. C., Baysal, B. E., Bosch, A. M., Rosenberg, E. H., Bröcker‐Vriends, A. H. J. T., van der Mey, A. G. L., van Ommen, G. B., Cornelisse, C. J., & Devilee, P. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1144 · Cited by 165
Research works printed but not linked: 1
- Lack EE . (1997). Atlas of Tumor Pathology: Tumours of the Adrenal Gland and Extra-Adrenal Paraganglia. Rosai J (ed). Armed Forces Institute of Pathology; Washington, pp. 223–259.
Cited by
Sorted by citations
Metabolic reprogramming and cancer progression
Faubert, B., Solmonson, A., & DeBerardinis, R. J. (2020) · Science · doi:10.1126/science.aaw5473 · Cited by 2,740
Mitochondrial tumour suppressors: a genetic and biochemical update
Gottlieb, E., & Tomlinson, I. P. M. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1737 · Cited by 626
Clinical Presentation and Penetrance of Pheochromocytoma/Paraganglioma Syndromes
Benn, D. E., Gimenez‐Roqueplo, A., Reilly, J. R., Bertherat, J. Y., Burgess, J. R., Byth, K., CROXSON, M. S., Dahia, P. L. M., Elston, M. S., Gimm, O., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1862 · Cited by 565
Self-citationMutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas.
Gimenez‐Roqueplo, A., Favier, J., Rustin, P., Rieubland, C., Crespin, M., Nau, V., Kien, P. K. V., Corvol, P. L., Plouin, P., & Jeunemaı̂tre, X. (2003) · PubMed · Cited by 542
Pheochromocytoma: State-of-the-Art and Future Prospects
Bravo, E. L., & Tagle, R. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0013 · Cited by 483
Bardella, C., Pollard, P. J., & Tomlinson, I. (2011) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2011.07.003 · Cited by 395
Ricketts, C. J., Forman, J., Rattenberry, E., Bradshaw, N., Lalloo, F. I., Izatt, L., Cole, T. R. P., Armstrong, R., Kumar, V. K. A., Morrison, P. J., et al. (2009) · Human Mutation · doi:10.1002/humu.21136 · Cited by 338
Gill, A. J., Benn, D. E., Chou, A. S. Y., Clarkson, A., Muljono, A., Meyer-Rochow, G. Y., Richardson, A. L., Sidhu, S. B., Robinson, B. G., & Clifton-Bligh, R. J. (2010) · Human Pathology · doi:10.1016/j.humpath.2009.12.005 · Cited by 281
Self-citationTimmers, H. J. L. M., Kozupa, A., Eisenhofer, G., Raygada, M. J., Adams, K. T., Solis, D. C., Lenders, J. W. M., & Pacák, K. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2315 · Cited by 278
Pasini, B., & Stratakis, C. A. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02111.x · Cited by 268
15 YEARS OF PARAGANGLIOMA: Clinical manifestations of paraganglioma syndromes types 1–5
Benn, D. E., Robinson, B. G., & Clifton-Bligh, R. J. (2015) · Endocrine Related Cancer · doi:10.1530/erc-15-0268 · Cited by 200
Self-citationCochaperone Binding to LYR Motifs Confers Specificity of Iron Sulfur Cluster Delivery
Maio, N., Singh, A., Uhrigshardt, H., Saxena, N., Tong, W.-H., & Rouault, T. A. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.01.015 · Cited by 167
Bayley, J., van Minderhout, I. J. H. M., Weiss, M. M., Jansen, J. C., Oomen, P. H. N., Menko, F. H., Pasini, B., Ferrando, B., Wong, N., Alpert, L., et al. (2006) · BMC Medical Genetics · doi:10.1186/1471-2350-7-1 · Cited by 158
The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase
Pollard, P., Wortham, N., & Tomlinson, I. (2003) · Annals of Medicine · doi:10.1080/07853890310018458 · Cited by 159
Genetic insights into OXPHOS defect and its role in cancer
Chandra, D., & Singh, K. K. (2010) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2010.10.023 · Cited by 155
The clinical phenotype of mosaicism for genome‐wide paternal uniparental disomy: Two new reports
Wilson, M., Peters, G. B., Bennetts, B., McGillivray, G., Wu, Z. H., Poon, C. J., & Algar, E. M. (2007) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.32172 · Cited by 143
Jiménez, C., Cote, G. J., Arnold, A., & Gagel, R. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2178 · Cited by 135
Surgical management of hereditary pheochromocytoma1
Yip, L., Lee, J. E., Shapiro, S. E., Waguespack, S. G., Sherman, S. I., Hoff, A. O., Gagel, R. F., Arens, J. F., & Evans, D. B. (2004) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2003.12.001 · Cited by 127
On the association of succinate dehydrogenase mutations with hereditary paraganglioma
Baysal, B. E. (2003) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2003.08.004 · Cited by 106
Head and neck paragangliomas: Report of 175 patients (1989–2010)
Papaspyrou, K., Mewes, T., Rossmann, H., Fottner, C., Schneider-Rätzke, B., Bartsch, O., Schreckenberger, M., Lackner, K. J., Amedee, R. G., & Mann, W. J. (2011) · Head & Neck · doi:10.1002/hed.21790 · Cited by 103
Douwes Dekker, P., Hogendoorn, P., Kuipers‐Dijkshoorn, N., Prins, F., van Duinen, S., Taschner, P., van der Mey, A., & Cornelisse, C. (2003) · The Journal of Pathology · doi:10.1002/path.1461 · Cited by 94
Yoon, Y.-S., Byun, H.-O., Cho, H., Kim, B.-K., & Yoon, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308489200 · Cited by 91
Management of head and neck paragangliomas: Review of 120 patients
Papaspyrou, K., Mann, W. J., & Amedee, R. G. (2008) · Head & Neck · doi:10.1002/hed.20967 · Cited by 85
Paraganglioma, neuroblastoma, and a SDHB mutation: Resolution of a 30‐year‐old mystery
Schimke, R. N., Collins, D. L., & Stolle, C. A. (2010) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.33384 · Cited by 85
An Alu-mediated partial SDHC deletion causes familial and sporadic paraganglioma
Baysal, B. E., Willett-Brozick, J. E., Filho, P. A. A., Lawrence, E. C., Myers, E. N., & Ferrell, R. E. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2004.019224 · Cited by 78
Byun, H., Kim, H. Y., Lim, J. J., Seo, Y., & Yoon, G. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21741 · Cited by 74
Genomic imprinting and environment in hereditary paraganglioma
Baysal, B. E. (2004) · American Journal of Medical Genetics Part C Seminars in Medical Genetics · doi:10.1002/ajmg.c.30018 · Cited by 69
Phaeochromocytomas and sympathetic paragangliomas
Petri, B., van Eijck, C. H. J., de Herder, W. W., Wagner, A., & de Krijger, R. R. (2009) · British journal of surgery · doi:10.1002/bjs.6821 · Cited by 64
Mutations of the SDHB and SDHD genes
Pawlu, C., Bausch, B., & Neumann, H. P. H. (2005) · Familial Cancer · doi:10.1007/s10689-004-4227-4 · Cited by 60
Genetic basis of phaeochromocytoma and paraganglioma
Benn, D. E., & Robinson, B. G. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.07.005 · Cited by 55
Self-citationPenetrance and clinical consequences of a gross SDHB deletion in a large family
Solis, D. C., Burnichon, N., Timmers, H., Raygada, M. J., Kozupa, A., Merino, M. J., Makey, D., Adams, K. T., Vénisse, A., Gimenez‐Roqueplo, A., et al. (2009) · Clinical Genetics · doi:10.1111/j.1399-0004.2009.01157.x · Cited by 55
Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma
Astuti, D., Morris, M. R., Krona, C. C., Abel, F., Gentle, D., Martinsson, T., Kogner, P., Neumann, H. P. H., Voutilainen, R., Eng, C., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602202 · Cited by 49
Yang, C., Matro, J. C., Huntoon, K. M., Ye, D. Y., Huynh, T., Fliedner, S. M. J., Breza, J., Jr., Zhuang, Z., & Pacák, K. (2012) · The FASEB Journal · doi:10.1096/fj.12-210146 · Cited by 52
Chen, J., Férec, C., & Cooper, D. N. (2009) · Human Mutation · doi:10.1002/humu.21088 · Cited by 49
Genetic mechanisms of human hypertension and their implications for blood pressure physiology
Seidel, E., & Scholl, U. I. (2017) · Physiological Genomics · doi:10.1152/physiolgenomics.00032.2017 · Cited by 52
Genetic and epigenetic profile of sporadic pheochromocytomas
Cascón, A., Ruiz-Llorente, S., Fraga, M. F., Leton, R., Telleria, D., Sastre, J., Diez, J. J., Diaz-Guerra, G. M., Perez, J. A. D., Benitez, J., et al. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.012658 · Cited by 49
Simi, L., Sestini, R., Ferruzzi, P., Gaglianò, M. S., Gensini, F., Mascalchi, M., Guerrini, L., Pratesi, C., Pinzani, P., Nesi, G., et al. (2005) · Journal of Medical Genetics · doi:10.1136/jmg.2004.030353 · Cited by 47
Cancer morphogenesis: role of mitochondrial failure.
Fosslien, E. (2008) · PubMed · Cited by 45
Mitochondrial DNA and carcinogenesis (Review)
Grzybowska‐Szatkowska, L., & Ślaska, B. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1027 · Cited by 43
Clinical Characteristics of Pheochromocytoma Patients With Germline Mutations in SDHD
Dannenberg, H., van Nederveen, F. H., Abbou, M., Verhofstad, A. A. J., Komminoth, P., de Krijger, R. R., & Dinjens, W. N. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.07.198 · Cited by 45
Clinical utility of chromogranin A in SDH x‐related paragangliomas
Zuber, S. M., WESLEY, R. A., Prodanov, T., Eisenhofer, G., Pacák, K., & Kantorovich, V. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12245 · Cited by 42
Tsang, V., Dwight, T., Benn, D. E., Meyer-Rochow, G. Y., Gill, A. J., Sywak, M. S., Sidhu, S., Veivers, D., Sue, C. M., Robinson, B. G., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-13-0519 · Cited by 42
Self-citationGenetic defects in the oxidative phosphorylation (OXPHOS) system
Janssen, R. J. R. J., van den Heuvel, L. P., & Smeitink, J. A. M. (2004) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.4.2.143 · Cited by 41
Comprehensive Overview of the Amide Linker Modification in the Succinate Dehydrogenase Inhibitors
Zeng, L.-Q., Chen, Q., Wei, G., Chen, W., Zhu, X., & Yang, G. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c05854 · Cited by 40
Bilateral Adrenal Medullary Hyperplasia Associated With an SDHB Mutation
Grogan, R. H., Pacák, K., Pasche, L., Huynh, T., & Greco, R. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.2156 · Cited by 40
Phaeochromocytoma: current concepts
Alderazi, Y., Yeh, M. W., Robinson, B. G., Benn, D. E., Sywak, M. S., Learoyd, D., Delbridge, L., & Sidhu, S. B. (2005) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb06997.x · Cited by 40
Self-citationvan Houtum, W. H., Corssmit, E. P. M., Dekker, P. B. D., Jansen, J. C., van der Mey, A. G. L., Bröcker-Vriends, A. H. J. T., Taschner, P. E. M., Losekoot, M., Frölich, M. A., Stokkel, M. P. M., et al. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.01833 · Cited by 40
Aarts, M., Dannenberg, H., deLeeuw, R. J., van Nederveen, F. H., Verhofstad, A. A. J., Lenders, J. W. M., Dinjens, W. N. M., Speel, E. M., Lam, W. L., & de Krijger, R. R. (2005) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20268 · Cited by 37
Abu‐Amero, K. K., Alzahrani, A. S., Zou, M., & Shi, Y. (2005) · Oncogene · doi:10.1038/sj.onc.1209094 · Cited by 38
Genetic Testing for Pheochromocytoma-associated Syndromes
Pawlu, C., Bausch, B., Reisch, N., & Neumann, H. P. H. (2005) · Annales d Endocrinologie · doi:10.1016/s0003-4266(05)81749-4 · Cited by 35
Panizza, E., Ercolino, T., Mori, L., Rapizzi, E., Castellano, M., Opocher, G., Ferrero, I., Neumann, H. P. H., Mannelli, M., & Goffrini, P. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds487 · Cited by 39
High-frequency actionable pathogenic exome variants in an average-risk cohortPreprint
Rego, S. M., Dagan‐Rosenfeld, O., Zhou, W., Sailani, M. R., Limcaoco, P., Colbert, E., Avina, M., Wheeler, J., Craig, C. M., Salins, D. N., et al. (2018) · Molecular Case Studies · doi:10.1101/mcs.a003178 · Cited by 36
Oxidative Phosphorylation System in Gastric Carcinomas and Gastritis
Feichtinger, R. G., Neureiter, D., Skaria, T., Weßler, S., Cover, T. L., Mayr, J. A., Zimmermann, F., Posselt, G., Sperl, W., & Kofler, B. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/1320241 · Cited by 33
Gladitz, J., Klink, B., & Seifert, M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0544-y · Cited by 33
Wong, M. Y., Andrews, K. A., Challis, B., Park, S., Acerini, C. L., Maher, E. R., & Casey, R. T. (2018) · Clinical Endocrinology · doi:10.1111/cen.13926 · Cited by 34
Castellano, M., Mori, L., Giacchè, M., Agliozzo, E., Tosini, R., Panarotto, A., Cappelli, C., Mulatero, P., Cumetti, D., Veglio, F., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.016 · Cited by 30
Holt, D. E., Henthorn, P. S., Howell, V. M., Robinson, B. G., & Benn, D. E. (2014) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2014.03.007 · Cited by 29
Self-citationPatócs, A., Karádi, É., Tóth, M., Varga, I., Szücs, N., Balogh, K., Majnik, J., Gláz, E., & Rácz, K. (2004) · European Journal of Cancer Prevention · doi:10.1097/00008469-200410000-00008 · Cited by 29
Maier-Woelfle, M., Brändle, M., Komminoth, P., Saremaslani, P., Schmid, S., Locher, T., Heitz, P. U., Krull, I., Galeazzi, R. L., Schmid, C., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031236 · Cited by 28
Molecular Genetic Alterations in Adrenal and Extra-Adrenal Pheochromocytomas and Paragangliomas
Dannenberg, H., Komminoth, P., Dinjens, W. N. M., Speel, E. M., & de Krijger, R. R. (2003) · Endocrine Pathology · doi:10.1385/ep:14:4:329 · Cited by 28
The Occurrence of SDHB Gene Mutations in Pheochromocytoma
van Nederveen, F. H., Dinjens, W. N. M., Korpershoek, E., & de Krijger, R. R. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.018 · Cited by 26
Targeting Heat Shock Protein 90 for the Treatment of Malignant Pheochromocytoma
Giubellino, A., Sourbier, C., Lee, M.-J., Scroggins, B., Bullova, P., Landau, M. S., Ying, W., Neckers, L., Trepel, J. B., & Pacák, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056083 · Cited by 25
SDHB, SDHC, and SDHD mutation screen in sporadic and familial head and neck paragangliomas
Mhatre, A., Li, Y., Feng, L., Gasperin, A. C. H., & Lalwani, A. K. (2004) · Clinical Genetics · doi:10.1111/j.1399-0004.2004.00328.x · Cited by 26
Research progress on the pathogenesis of the SDHB mutation and related diseases
Liu, C., Zhou, D., Yang, K., Xu, N., Peng, J., & Zhu, Z. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115500 · Cited by 23
Weber, A., Hoffmann, M. M., Neumann, H. P. H., & Erlic, Z. (2012) · Hormones and Cancer · doi:10.1007/s12672-012-0113-y · Cited by 23
Kiss, N. B., Muth, A., Stenman, A., Juhlin, C. C., Geli, J., Bäckdahl, M., Höög, A., Wängberg, B., Nilsson, O., Ahlman, H., et al. (2012) · Endocrine Related Cancer · doi:10.1530/erc-12-0267 · Cited by 22
Müller, U. (2011) · Neurogenetics · doi:10.1007/s10048-011-0280-y · Cited by 22
McDonnell, C. M., Benn, D. E., Marsh, D. J., Robinson, B. G., & Zacharin, M. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02122.x · Cited by 21
Self-citationPapaspyrou, K., Rossmann, H., Fottner, C., Weber, M. M., Mann, W. J., Lackner, K. J., & Helling, K. (2008) · Head & Neck · doi:10.1002/hed.20746 · Cited by 19
Montani, M., Schmitt, A. M., Schmid, S., Locher, T., Saremaslani, P., Heitz, P. U., Komminoth, P., & Perren, A. A. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00996 · Cited by 17
Alterations of respiratory chain complexes in sporadic pheochromocytoma
Kofler, B. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e233 · Cited by 17
Urinary Bladder Paragangliomas: Analysis of Succinate Dehydrogenase and Outcome
Gupta, S., Zhang, J., Rivera, M., & Erickson, L. A. (2016) · Endocrine Pathology · doi:10.1007/s12022-016-9439-2 · Cited by 16
Acromegaly in a multiple endocrine neoplasia type 1 (MEN1) family with low penetrance of the disease
Dreijerink, K. M. A., van Beek, A. P., Lentjes, E. G. W. M., Post, J. G., van der Luijt, R. B., van Dijk, M. R., & Lips, C. J. M. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02022 · Cited by 16
Jeffery, J., Devendra, D., Farrugia, J., Gardner, D. S.-L., Murphy, M., Williams, R., Ayling, R. M., & Wilkin, T. J. (2006) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1258/000456306776021517 · Cited by 15
Novel Germline Mutations in the SDHB and SDHD Genes in Japanese Pheochromocytomas
Isobe, K., Minowada, S., Tatsuno, I., Suzukawa, K., Nissato, S., Nanmoku, T., Hara, H., YASHIRO, T., Kawakami, Y., & Takekoshi, K. (2007) · Hormone Research in Paediatrics · doi:10.1159/000099655 · Cited by 15
Mutational load in carotid body tumor
Kudryavtseva, A. V., Lukyanova, E., Kalinin, D. V., Zaretsky, A. R., Pokrovsky, A. V., Golovyuk, A. L., Fedorova, M., Pudova, E. A., Kharitonov, S., Pavlov, V., et al. (2019) · BMC Medical Genomics · doi:10.1186/s12920-019-0483-x · Cited by 14
68Ga-DOTATATE PET–CT imaging in carotid body paragangliomas
Şimşek, D. H., Şanlı, Y., Kuyumcu, S., Başaran, B., & Mudun, A. (2018) · Annals of Nuclear Medicine · doi:10.1007/s12149-018-1242-3 · Cited by 14
SDH Mutations in Patients Affected by Paraganglioma Syndromes
Mannelli, M., Simi, L., Ercolino, T., Gaglianò, M. S., Becherini, L., Vinci, S., Sestini, R., Gensini, F., Pinzani, P., Mascalchi, M., et al. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1353.019 · Cited by 13
Pheochromocytoma/Paraganglioma: A Poster Child for Cancer Metabolism
Tevosian, S. G., & Ghayee, H. K. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01991 · Cited by 11
Saito, T., Saito, Y., Matsumura, K., Tsubota, Y., Maniwa, T., Kaneda, H., Minami, K.-I., Sakaida, N., Uemura, Y., Kawa, G., et al. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-178 · Cited by 11
Takeuchi, T., Adachi, Y., & Ohtsuki, Y. (2005) · DNA and Cell Biology · doi:10.1089/dna.2005.24.339 · Cited by 11
An apparently sporadic paraganglioma with an SDHB gene germline mutation presenting at age 68 years
Elston, M. S., Benn, D. E., Robinson, B. G., & Conaglen, J. V. (2006) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2006.01023.x · Cited by 11
Self-citationMaher, E. R. (2006) · British Medical Bulletin · doi:10.1093/bmb/ldl002 · Cited by 7
Bronchial Paraganglioma with SDHB Deficiency
Ghigna, M., Dorfmüller, P., Crutu, A., Fadel, É., & de Montpréville, V. (2016) · Endocrine Pathology · doi:10.1007/s12022-016-9422-y · Cited by 6
Oxidative Phosphorylation Disease
Shoffner, J. M. (2005) · Oxidative stress and disease · doi:10.1201/9781420028843.ch4 · Cited by 6
Prasad, P. K., Kant, J. A., Wills, M. L., O’Leary, M. F., Lovvorn, H. N., & Yang, E. (2009) · Cancer Genetics and Cytogenetics · doi:10.1016/j.cancergencyto.2009.04.009 · Cited by 5
Sato, H., Kanai, G., Hirabayshi, K., Kajiwara, H., Itoh, J., & OSAMURA, R. Y. (2010) · Endocrine · doi:10.1007/s12020-010-9365-x · Cited by 5
Mikoshiba, T., Yoshihama, K., Ito, F., Sekimizu, M., Nakamura, S., Nagai, R., Akiyama, T., Matsubara, K., Obara, H., & Ozawa, H. (2021) · International Cancer Conference Journal · doi:10.1007/s13691-021-00522-x · Cited by 5
Genetic Syndromes Associated with Adrenal Tumors
Åkerström, G., & Hellman, P. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_25 · Cited by 5
High Frequency Actionable Pathogenic Exome Mutations in an Average-Risk CohortPreprint
Rego, S. M., Dagan‐Rosenfeld, O., Zhou, W., Sailani, M. R., Limcaoco, P., Colbert, E., Avina, M., Wheeler, J., Craig, C. M., Salins, D. N., et al. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/151225 · Cited by 5
Boucher, A., Oudihat, M., Martin, H., Dufour, P. A., Laporta, J., Sirard, M., & Ouellet, V. (2025) · Journal of Dairy Science · doi:10.3168/jds.2025-27306 · Cited by 4
Novel Germline SDHB Mutation in a 35-Year-Old Male with Malignant Bladder Paraganglioma
Elaraj, D. M., Sturgeon, C., Heller, M. B., & Aleppo, G. (2010) · World Journal of Endocrine Surgery · doi:10.5005/jp-journals-10002-1038 · Cited by 2
Genetic Diagnosis of Pheochromocytoma
Takekoshi, K., Isobe, K., & Kawakami, Y. (2008) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.97.2558 · Cited by 2
Paraganglioma and Pheochromocytoma
Iacobone, M., & Torresan, F. (2021) · Springer eBooks · doi:10.1007/978-3-030-62241-1_15 · Cited by 2
Identification and Characterization of Plant Circular RNAs
Zhou, Y.-F., Sun, Y., & Chen, Y. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1645-1_1 · Cited by 1
Nuclear DNA and Oxidative Phosphorylation
van den Heuvel, L. P., & Smeitink, J. A. M. (2004) · Springer eBooks · doi:10.1007/0-387-26992-4_7 · Cited by 1
The Genetic Background of Hereditary Tumor Diseases
Steinlein, O. K. (2008) · doi:10.1002/9783527627523.ch2
Miettinen, M. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511781049.027
Pediatric Paragangliomas: Role of Germline Mutation in Succinate Dehydrogenase
Prasad, P. K., & Yang, E. (2012) · Pediatric cancer · doi:10.1007/978-94-007-2957-5_30
Cancer morphogenesis: role of mitochondrial failure.
Fosslien, E. (2008) · PubMed · Cited by 45
Metadata
- Authors
- Benn, D. E., Croxson, M. S., Tucker, K., Bambach, C. P., Richardson, A. L., Delbridge, L., Pullan, P. T., Hammond, J., Marsh, D. J., & Robinson, B. G.
- Affiliations
- The University of Sydney (AU)
- Auckland City Hospital (NZ)
- UNSW Sydney (AU)
- Royal North Shore Hospital (AU)
- The University of Western Australia (AU)
- Corresponding author
- Marsh, Deborah J
- Robinson, Bruce G
- Venue
- Oncogene
- Published
- 2003-03-05
- Volume
- 22
- Issue
- 9
- Pages
- 1358-1364
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1972330784
- Cited by
- 108
- References
- 23
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2021: 3 · 2020: 1 · 2019: 1 · 2018: 5 · 2017: 3 · 2016: 2 · 2015: 1 · 2014: 4 · 2013: 2 · 2012: 7
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
- Health Sciences › Medicine › Clinical Neurology › Neurofibromatosis and Schwannoma Cases
- Keywords
- succinate dehydrogenase subunit B, SDHB mutation, pheochromocytoma, paraganglioma, SDHD, succinate dehydrogenase, germline mutations, somatic mutations, loss of heterozygosity, 1p36, RET mutations, splice site mutation, intronic polymorphism, penetrance
- MeSH terms
- Adolescent, Adrenal Gland Neoplasms, Adult, Australia, Child, Chromosomes, Human, Pair 1, DNA Mutational Analysis, DNA, Neoplasm, Head and Neck Neoplasms, Humans, Introns, Iron-Sulfur Proteins, Male, Middle Aged, Multienzyme Complexes, Neoplasm Proteins, Multiple Endocrine Neoplasia, Neoplastic Syndromes, Hereditary, Oxidoreductases, Paraganglioma, Pedigree, Pheochromocytoma, Retroperitoneal Neoplasms, Succinate Dehydrogenase, Frameshift Mutation, Age of Onset, Germ-Line Mutation, Loss of Heterozygosity, Mutation, Missense, Protein Subunits, RNA Splice Sites, Electron Transport Complex II
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review